Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-20 to 2024-03-21
Current total value of award: $2443.5
Description: 4564027754!FASENRA 30 MG/ML SYRINGEML